Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 01, 2024

BUY
$268.87 - $324.56 $189,553 - $228,814
705 New
705 $200,000
Q4 2023

Feb 07, 2024

SELL
$255.7 - $288.46 $38,355 - $43,269
-150 Reduced 17.2%
722 $207,000
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $190,662 - $236,713
872 New
872 $234,000
Q1 2023

May 10, 2023

SELL
$225.79 - $275.2 $4,741 - $5,779
-21 Reduced 0.84%
2,482 $600,000
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $10,764 - $13,677
-47 Reduced 1.84%
2,503 $657,000
Q2 2022

Jul 28, 2022

SELL
$230.71 - $256.74 $2,768 - $3,080
-12 Reduced 0.47%
2,550 $620,000
Q1 2022

Apr 28, 2022

BUY
$219.27 - $242.57 $66,658 - $73,741
304 Added 13.46%
2,562 $619,000
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $10,938 - $12,518
55 Added 2.5%
2,258 $507,000
Q3 2021

Oct 28, 2021

BUY
$212.27 - $248.7 $3,396 - $3,979
16 Added 0.73%
2,203 $468,000
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $305,522 - $338,955
-1,308 Reduced 37.42%
2,187 $533,000
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $221,022 - $257,565
996 Added 39.86%
3,495 $869,000
Q4 2020

Jan 25, 2021

BUY
$216.38 - $257.67 $254,246 - $302,762
1,175 Added 88.75%
2,499 $574,000
Q3 2020

Nov 04, 2020

BUY
$234.65 - $260.95 $11,028 - $12,264
47 Added 3.68%
1,324 $336,000
Q2 2020

Aug 07, 2020

SELL
$197.81 - $242.74 $708,357 - $869,251
-3,581 Reduced 73.71%
1,277 $301,000
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $34,261 - $45,439
188 Added 4.03%
4,858 $984,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $15,136 - $19,456
80 Added 1.74%
4,670 $1.13 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $46,487 - $55,701
267 Added 6.18%
4,590 $888,000
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $49,009 - $57,450
294 Added 7.3%
4,323 $796,000
Q1 2019

May 01, 2019

BUY
$180.87 - $203.88 $94,956 - $107,037
525 Added 14.98%
4,029 $765,000
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $40,496 - $47,272
227 Added 6.93%
3,504 $682,000
Q3 2018

Oct 31, 2018

BUY
$185.29 - $208.89 $23,346 - $26,320
126 Added 4.0%
3,277 $679,000
Q2 2018

Aug 10, 2018

BUY
$166.05 - $186.51 $23,911 - $26,857
144 Added 4.79%
3,151 $581,000
Q1 2018

May 07, 2018

BUY
$169.43 - $198.0 $22,195 - $25,938
131 Added 4.55%
3,007 $512,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $9,621 - $10,749
57 Added 2.02%
2,876 $500,000
Q3 2017

Nov 07, 2017

BUY
$167.29 - $191.0 $2,007 - $2,292
12 Added 0.43%
2,819 $525,000
Q2 2017

Aug 11, 2017

BUY
N/A
2,807
2,807 $483,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Harfst & Associates, Inc. Portfolio

Follow Harfst & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.